CIMCX
Price
$27.40
Change
+$0.08 (+0.29%)
Updated
Jun 2 closing price
Net Assets
146.54B
FQTEX
Price
$14.98
Change
-$0.00 (-0.00%)
Updated
Jun 2 closing price
Net Assets
625.77M
Interact to see
Advertisement

CIMCX vs FQTEX

Header iconCIMCX vs FQTEX Comparison
Open Charts CIMCX vs FQTEXBanner chart's image
CIMCX vs FQTEX Comparison Chart in %
View a ticker or compare two or three
VS
CIMCX vs. FQTEX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CIMCX is a Buy and FQTEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CIMCX has more cash in the bank: 147B vs. FQTEX (626M). FQTEX pays higher dividends than CIMCX: FQTEX (6.38) vs CIMCX (2.73). CIMCX was incepted earlier than FQTEX: CIMCX (24 years) vs FQTEX (7 years). CIMCX (1.35) is less costly to investors than FQTEX (0.08). FQTEX is a more actively managed with annual turnover of: 103.34 vs. CIMCX (65.00). FQTEX has a lower initial minimum investment than CIMCX: FQTEX (0) vs CIMCX (250). FQTEX annual gain was more profitable for investors over the last year : 26.61 vs. CIMCX (8.06). FQTEX return over 5 years is better than : 59.61 vs. CIMCX (20.12).
CIMCXFQTEXCIMCX / FQTEX
Total Expense Ratio1.350.00-
Annual Report Gross Expense Ratio1.350.081,688%
Fund Existence24 years7 years-
Gain YTD5.65410.00956%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets147B626M23,482%
Annual Yield % from dividends2.736.3843%
Returns for 1 year8.0626.6130%
Returns for 3 years33.0761.1754%
Returns for 5 years20.1259.6134%
Returns for 10 years67.70N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JLCAX23.77N/A
N/A
JPMorgan US Large Cap Core Plus A
OINCX25.45N/A
N/A
JPMorgan Equity Income C
PHSKX37.47N/A
N/A
Virtus KAR Mid-Cap Growth A
MXNSX22.96N/A
N/A
Empower S&P SmallCap 600® Index L
RYCFX45.37N/A
N/A
Rydex Biotechnology C